Open AccessCirculating Modified Metabolites and a Risk of ESRD in Patients With Type 1 Diabetes and Chronic Kidney Disease
Author(s) -
Monika A. Niewczas,
Anna V. Mathew,
Stephanie Croall,
Jaeman Byun,
Melissa Major,
Venkatta S. Sabisetti,
Adam M. Smiles,
Joseph V. Bonventre,
Subramaniam Pennathur,
Andrzej S. Królewski
Publication year - 2017
Publication title -
diabetes care
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.636
H-Index - 363
eISSN - 1935-5548
pISSN - 0149-5992
DOI - 10.2337/dc16-0173
Subject(s) - medicine , diabetes mellitus , kidney disease , type 2 diabetes , disease , intensive care medicine , endocrinology
Patients with type 1 diabetes (T1D) with impaired renal function are at increased risk for end-stage renal disease (ESRD). Although the rate of progression varies, determinants and mechanisms of this variation are unknown.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom